scholarly journals CD8+CD122+ regulatory T cells recognize activated T cells via conventional MHC class I–αβTCR interaction and become IL-10-producing active regulatory cells

2008 ◽  
Vol 20 (7) ◽  
pp. 937-947 ◽  
Author(s):  
Muhaimin Rifa'i ◽  
Zhe Shi ◽  
Shu-Yun Zhang ◽  
Young Ho Lee ◽  
Hiroshi Shiku ◽  
...  
Blood ◽  
2007 ◽  
Vol 110 (7) ◽  
pp. 2217-2218
Author(s):  
Jerzy W. Kupiec-Weglinski

The OX40 T-cell costimulatory molecule, critical for both survival and proliferation of activated T cells, has now been identified as a key negative regulator of Foxp3+ T regulatory cells (Tregs).


Blood ◽  
2012 ◽  
Vol 119 (15) ◽  
pp. 3373-3374 ◽  
Author(s):  
Terrence L. Geiger

In this issue of Blood, Plesa et al demonstrate that human Foxp3+ regulatory T cells can be redirected using MHC class I–restricted T-cell receptors (TCRs), showing a surprising lack of correlation of TCR affinity and their suppressive potency.1


Blood ◽  
2015 ◽  
Vol 126 (23) ◽  
pp. 2228-2228
Author(s):  
Liora M. Schultz ◽  
Niclas Olsson ◽  
Michael Khodadoust ◽  
Rupa Narayan ◽  
Idit Sagiv-Barfi ◽  
...  

Abstract Background: FOXP3 is a transcription factor of central importance to the inhibitory function of CD4+, CD25+ FOXP3+ T regulatory cells (Tregs). Tregs function as critical inhibitory immunoregulatory cells and have been reported to be increased in tumor-bearing individuals, inhibiting optimal T effector mediated anti-tumor cytotoxicity. Treg depletion targeting CD25, a surface marker of Tregs as well as activated T cells, has been validated in pre-clinical models as a promising adjunctive therapeutic approach to improving T cell mediated therapy and is currently being explored in clinical trials. However, because CD25 expression is not limited to Tregs, CD25-directed therapies may also result in the undesired depletion of effector T cells. Although FOXP3 expression is more restricted to Tregs as compared to CD25, its intranuclear localization has made it challenging to target therapeutically. Vaccination of mice against FOXP3 using FOXP3 mRNA-transfected dendritic cells has been explored and can elicit FOXP3 specific CTL mediated cytotoxicity. This work implies that FOXP3 mRNA-transfected dendritic cells process FOXP3 and present FOXP3 derived peptides on the cell surface. Direct expression of FOXP3 derived peptides on the surface of Tregs has however, not been previously demonstrated. Methods: We utilized mass spectrometry to investigate if FOXP3 derived peptides presented within MHC class I complex are expressed on the surface of Tregs. CD4+, CD25+ T cells were isolated from healthy donors using magnetic bead selection to enrich for Tregs. Surface class I MHC was immunoprecipitated using a pan-MHC class I anti- HLA-A, HLA-B and HLA-C antibody and associated peptides were eluted from their MHC complex using acid elution. Peptide and fragment masses were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and the spectra of resulting epitopes were matched to known protein sequences by SEQUEST. Results: Four unique FOXP3 derived peptides were identified from the primary donor samples enriched for FOXP3+ cells as described. Predictive HLA binding algorithms demonstrate that the peptides identified are predicted binders to the specific HLA alleles of the original donors. No FOXP3 derived peptides were identified from the CD4+, CD25- T cell fraction analyzed to date. Conclusions: This work directly demonstrates for the first time to our knowledge that, although FOXP3 is an intra-nuclear transcription factor, FOXP3 derived peptides are presented within class I MHC on the surface of Tregs, representing a targetable Treg associated surface protein complex. Disclosures Levy: Bullet Biotechnology, Inc.: Consultancy.


1998 ◽  
Vol 66 (8) ◽  
pp. S31
Author(s):  
D V Saborio ◽  
N C Chowdhury ◽  
M X Jin ◽  
M H Sayegh ◽  
A Chandraker ◽  
...  

2008 ◽  
Vol 181 (4) ◽  
pp. 2428-2437 ◽  
Author(s):  
Siguo Hao ◽  
Jinying Yuan ◽  
Shulin Xu ◽  
Manjunatha Ankathatti Munegowda ◽  
Yulin Deng ◽  
...  

1999 ◽  
Vol 8 (4) ◽  
pp. 375-381 ◽  
Author(s):  
David V. Saborio ◽  
Nepal C. Chowdhury ◽  
Ming-Xing Jin ◽  
Anil Chandraker ◽  
Mohamed H. Sayegh ◽  
...  

2003 ◽  
Vol 77 (6) ◽  
pp. 3799-3808 ◽  
Author(s):  
Hanna Lewicki ◽  
Antoinette Tishon ◽  
Dirk Homann ◽  
Honoré Mazarguil ◽  
Françoise Laval ◽  
...  

ABSTRACT CD4 and CD8 T lymphocytes infiltrate the parenchyma of mouse brains several weeks after intracerebral, intraperitoneal, or oral inoculation with the Chandler strain of mouse scrapie, a pattern not seen with inoculation of prion protein knockout (PrP−/−) mice. Associated with this cellular infiltration are expression of MHC class I and II molecules and elevation in levels of the T-cell chemokines, especially macrophage inflammatory protein 1β, IFN-γ-inducible protein 10, and RANTES. T cells were also found in the central nervous system (CNS) in five of six patients with Creutzfeldt-Jakob disease. T cells harvested from brains and spleens of scrapie-infected mice were analyzed using a newly identified mouse PrP (mPrP) peptide bearing the canonical binding motifs to major histocompatibility complex (MHC) class I H-2b or H-2d molecules, appropriate MHC class I tetramers made to include these peptides, and CD4 and CD8 T cells stimulated with 15-mer overlapping peptides covering the whole mPrP. Minimal to modest Kb tetramer binding of mPrP amino acids (aa) 2 to 9, aa 152 to 160, and aa 232 to 241 was observed, but such tetramer-binding lymphocytes as well as CD4 and CD8 lymphocytes incubated with the full repertoire of mPrP peptides failed to synthesize intracellular gamma interferon (IFN-γ) or tumor necrosis factor alpha (TNF-α) cytokines and were unable to lyse PrP−/− embryo fibroblasts or macrophages coated with 51Cr-labeled mPrP peptide. These results suggest that the expression of PrPsc in the CNS is associated with release of chemokines and, as shown previously, cytokines that attract and retain PrP-activated T cells and, quite likely, bystander activated T cells that have migrated from the periphery into the CNS. However, these CD4 and CD8 T cells are defective in such an effector function(s) as IFN-γ and TNF-α expression or release or lytic activity.


1992 ◽  
Vol 142 (1) ◽  
pp. 103-113 ◽  
Author(s):  
Sandra Demaria ◽  
Rise Schwab ◽  
Yuri Bushkin

Sign in / Sign up

Export Citation Format

Share Document